Fecal microbiota transplantation may be a viable treatment option for patients with cancer who have developed immunotherapy-induced colitis, according to results of a case series published in Nature Medicine.
FMT has been shown to be effective in treating patients with Clostridium difficile infections and inflammatory bowel disease but has not previously been tested as a treatment option in patients with cancer who have developed gastrointestinal side effects as a result of their immunotherapy.
Immunotherapy-induced colitis, the second most common side effect from immune checkpoint inhibitors,

Source link